BCL2 and hepatocellular carcinoma: Activated STAT3 has been shown to have anti-apoptotic activity and enhance the survival of malignant cells in HCC by activating the expression of anti-apoptotic protein Bcl-xL and Bcl-2 [38,39,40,41,42,43].